Principal Financial Group has reduced its holdings in
Universal Health Services, selling 5,655 shares. One UHS director also recently sold $308,515 in stock. The company has announced its Q3 2024 earnings and conference call date but faces potential financial implications due to a $535M judgment against its subsidiary. The judgement, which UHS plans to appeal, stems from negligence allegations. Current target prices and forecasts for UHS stock suggest stability and value for long-term investors. However, more than 100 former patients recently filed a major lawsuit against UHS for alleged abuse. Founder
Alan B. Miller is set to step down as CEO, handing over to President Marc D. Miller, while remaining as Executive Chairman of the Board. The future seems focused on next-generation healthcare, with
Hippocratic AI securing $53M investment backed by UHS, among others. Despite recent challenges, including a ransomware attack costing $67M, many industry watchers rate UHS as a strong value or momentum stock. Furthermore, a recent $12.5M class action ERISA settlement has developed. UHS continues its infrastructural expansions with recent groundbreaking events for new regional medical centers.
Universal Health Services Class B UHS News Analytics from Wed, 07 Dec 2016 08:00:00 GMT to Thu, 26 Dec 2024 08:00:00 GMT -
Rating 2
- Innovation -3
- Information 7
- Rumor -4
